AR222472A1 - Derivado de 1,1-dioxido de 4-hidroxi-2 alquil-3-carbamoil -2h-tieno-1,2-tiazina - Google Patents

Derivado de 1,1-dioxido de 4-hidroxi-2 alquil-3-carbamoil -2h-tieno-1,2-tiazina

Info

Publication number
AR222472A1
AR222472A1 AR273600A AR27360078A AR222472A1 AR 222472 A1 AR222472 A1 AR 222472A1 AR 273600 A AR273600 A AR 273600A AR 27360078 A AR27360078 A AR 27360078A AR 222472 A1 AR222472 A1 AR 222472A1
Authority
AR
Argentina
Prior art keywords
carbamoil
tieno
thiazine
hydroxy
derivative
Prior art date
Application number
AR273600A
Other languages
English (en)
Inventor
Dieter Binder
Otto Hromatka
Rudolf Dr Pfister
Paul Dr Zeller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to LU78083 priority Critical
Priority to CH790878 priority
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR222472A1 publication Critical patent/AR222472A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
AR273600A 1977-09-06 1978-09-06 Derivado de 1,1-dioxido de 4-hidroxi-2 alquil-3-carbamoil -2h-tieno-1,2-tiazina AR222472A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LU78083 1977-09-06
CH790878 1978-07-21

Publications (1)

Publication Number Publication Date
AR222472A1 true AR222472A1 (es) 1981-05-29

Family

ID=25702440

Family Applications (1)

Application Number Title Priority Date Filing Date
AR273600A AR222472A1 (es) 1977-09-06 1978-09-06 Derivado de 1,1-dioxido de 4-hidroxi-2 alquil-3-carbamoil -2h-tieno-1,2-tiazina

Country Status (28)

Country Link
US (1) US4180662A (es)
EP (1) EP0001113B1 (es)
JP (1) JPS6149318B2 (es)
AR (1) AR222472A1 (es)
AT (1) AT364851B (es)
AU (1) AU518216B2 (es)
BR (1) BR7805845A (es)
CA (1) CA1103246A (es)
CS (1) CS202019B2 (es)
DE (2) DE2838851A1 (es)
DK (1) DK148280C (es)
ES (1) ES473074A1 (es)
FI (1) FI63587C (es)
GB (1) GB2003877B (es)
GR (1) GR73066B (es)
HK (1) HK1085A (es)
HU (1) HU176979B (es)
IE (1) IE47261B1 (es)
IL (1) IL55465A (es)
IT (1) IT1099046B (es)
LU (1) LU90207I2 (es)
MC (1) MC1212A1 (es)
NL (1) NL7809015A (es)
NO (1) NO149174C (es)
NZ (1) NZ188320A (es)
PH (1) PH13949A (es)
PT (1) PT68515A (es)
SE (1) SE7809348L (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
JPH0229679B2 (es) * 1981-12-22 1990-07-02 Mitsui Toatsu Chemicals
EP0103142B1 (de) * 1982-09-09 1987-04-22 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Thieno(2,3-e)-1,2-thiazin-Derivate
GR80576B (en) * 1983-10-17 1984-11-29 Fujisawa Pharmaceutical Co Thiazine derivatives, process for preparation thereof and pharmaceutical composition comprising the same
US4551452A (en) * 1983-12-21 1985-11-05 Pfizer Inc. Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
JPS60184077A (en) * 1984-02-23 1985-09-19 Pfizer Antiinflammatory oxime precursor drug
US4656265A (en) * 1984-06-21 1987-04-07 Pfizer Inc. Cyclic prodrugs of antiinflammatory oxicams
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
US4610982A (en) * 1985-06-03 1986-09-09 Pfizer Inc. Anti-inflammatory benzo- and thieno-1,2-thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
HU203762B (en) * 1987-06-10 1991-09-30 Pfizer Process for producing 3,4-dihydro-2-alkyl-3-oxo-n-aryl2h-(1)-benzothieno(3,2-e)-1,2-thiazino-4- -carboxamide-1,1-dioxides and pharmaceutical compositions containing them
NZ226477A (en) * 1987-10-29 1990-07-26 Cl Pharma Substituted thieno (2,3-e)-1,2 thiazine derivatives and pharmaceutical compositions
ATA39088A (de) 1988-02-18 1990-06-15 Binder Dieter Dr Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung
AT390060B (de) * 1988-05-02 1990-03-12 Cl Pharma Verfahren zur herstellung von 5-chlor-3chlorsulfonyl-2-thiophencarbonsaeureestern
JPH01316315A (en) * 1988-06-16 1989-12-21 Taisho Pharmaceut Co Ltd Plaster
JPH01316314A (en) * 1988-06-16 1989-12-21 Taisho Pharmaceut Co Ltd Wet compress
DE4141218A1 (de) * 1991-12-13 1993-06-17 Luitpold Werk Chem Pharm Thiadiazincarbonsaeureamidderivate, verfahren zu ihrer herstellung und arzneimittel
AT399880B (de) * 1992-07-03 1995-08-25 Chem Pharm Forsch Gmbh Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung
AT400845B (de) * 1993-12-06 1996-03-25 Chem Pharm Forsch Gmbh Neue thienothiazinderivate, ein verfahren zu ihrer herstellung und ihre verwendung
EP0658559A1 (de) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
AT400437B (de) * 1993-12-14 1995-12-27 Chem Pharm Forsch Gmbh Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung
AT400568B (de) * 1994-05-18 1996-01-25 Chem Pharm Forsch Gmbh Neue n-heterocyclische thienothiazincarboxamide, verfahren zu ihrer herstellung und ihre verwendung
DE19747625A1 (de) * 1997-10-29 1999-05-06 Bayer Ag Verfahren zur Herstellung von 3,5-Dimethylisoxazol-4-sulfochlorid
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
DE19933260A1 (de) 1999-07-15 2001-01-18 Bayer Ag Substituierte Thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one
PL208713B1 (pl) * 2001-06-11 2011-05-31 Virochem Pharma Inc Związek stanowiący pochodną tiofenu, kompozycja farmaceutyczna zawierająca taki związek i jego zastosowanie
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
CN1171892C (zh) * 2001-06-25 2004-10-20 李晶 具有抗炎镇痛活性的噻吩并噻嗪化合物及其制备方法和用途
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
AT413944B (de) * 2003-05-27 2006-07-15 Binder Eva Dkfm Verwendung von oxicam-verbindungen
CN1266155C (zh) * 2003-08-01 2006-07-26 浙江震元制药有限公司 6-氯-4-羟基-2-甲基-2H-噻吩并(2,3-e)-1,2-噻嗪-1,1-二氧化物-3-羧酸酯的合成方法
DE102004010812A1 (de) * 2004-03-05 2005-09-22 Bayer Cropscience Ag Unkrautbekämpfungsverfahren
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
WO2005115992A1 (en) 2004-05-23 2005-12-08 Housey Pharmaceuticals, Inc. Theramutein modulators
JP5030947B2 (ja) 2005-05-13 2012-09-19 ヴァイロケム・ファーマ・インコーポレーテッド フラビウイルス感染の治療及び予防のための化合物及び方法
JP2009523408A (ja) * 2005-11-23 2009-06-25 ジェラルド・エム・ハウシー タンパク質モジュレーターを同定、合成、最適化および解析する化合物群および方法群
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
JP5378221B2 (ja) 2006-10-11 2013-12-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するオキシカム及び関連化合物の正荷電水溶性プロドラッグ
AP2579A (en) * 2006-11-15 2013-01-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
EP2170826A4 (en) * 2007-06-04 2012-11-07 Techfields Inc NSAIM PRODRUGS WITH VERY HIGH SKIN AND MEMBRANE PENETRATION RATES AND ITS NEW MEDICAL USES
CN101314598B (zh) * 2008-07-14 2012-03-21 浙江工业大学 5-氯-2-羧酸甲酯-3-甲胺基磺酰噻吩的合成新工艺
CN108218895B (zh) * 2018-04-13 2019-06-18 北京金城泰尔制药有限公司沧州分公司 一锅法合成氯诺昔康中间体的方法
CN112645925A (zh) * 2020-12-25 2021-04-13 北京金城泰尔制药有限公司 氯诺昔康中间体5-氯-3-甲基磺酰胺噻吩-2-羧酸甲酯的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1308533A (en) 1969-06-02 1973-02-21 Pfizer Benzothiazine dioxides as anti-thombotic agents
US3787324A (en) 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3821211A (en) * 1972-03-10 1974-06-28 Warner Lambert Co Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolycarbamoyl)-2-methyl-2h-1,2-benzothiazine 1,1-dioxide
CA1010990A (en) 1973-06-06 1977-05-24 Leopold H. O'donnell Video tape recording animation system
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
IL47877A (en) * 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
MC1135A1 (fr) * 1976-02-23 1977-11-18 Hoffmann La Roche Derives de thiazine

Also Published As

Publication number Publication date
GB2003877B (en) 1982-03-17
EP0001113A1 (de) 1979-03-21
NO149174B (no) 1983-11-21
IT7827396D0 (it) 1978-09-06
DK148280B (da) 1985-05-28
AU3938978A (en) 1980-03-06
PH13949A (en) 1980-11-04
IE47261B1 (en) 1984-02-08
FI63587B (fi) 1983-03-31
EP0001113B1 (de) 1981-11-11
DE2838851A1 (de) 1979-03-22
BR7805845A (pt) 1979-04-24
NO783032L (no) 1979-03-07
CA1103246A (en) 1981-06-16
IT1099046B (it) 1985-09-18
IE781788L (en) 1979-03-06
PT68515A (en) 1978-10-01
DK148280C (da) 1985-11-18
JPS6149318B2 (es) 1986-10-29
CS202019B2 (en) 1980-12-31
NZ188320A (en) 1981-01-23
IL55465D0 (en) 1978-10-31
MC1212A1 (fr) 1979-05-18
JPS5448792A (en) 1979-04-17
NO149174C (no) 1984-02-29
US4180662A (en) 1979-12-25
ES473074A1 (es) 1979-10-16
HU176979B (hu) 1981-06-28
LU90207I2 (fr) 1998-04-29
FI782737A (fi) 1979-03-07
AU518216B2 (en) 1981-09-17
SE7809348L (sv) 1979-03-07
GR73066B (es) 1984-01-30
GB2003877A (en) 1979-03-21
IL55465A (en) 1982-02-28
DE2861316D1 (en) 1982-01-14
FI63587C (fi) 1983-07-11
HK1085A (en) 1985-01-11
ATA642178A (de) 1981-04-15
AT364851B (de) 1981-11-25
NL7809015A (nl) 1979-03-08
DK392778A (da) 1979-03-07

Similar Documents

Publication Publication Date Title
AR222472A1 (es) Derivado de 1,1-dioxido de 4-hidroxi-2 alquil-3-carbamoil -2h-tieno-1,2-tiazina
IT1109641B (it) Calzatura particolarmente scarpasportiva
SE7805879L (sv) Mevalonolaktonderivat
PT68458A (pt) Triphenylalkene derivatives
BR7805649A (pt) Composicao de arrebentamento
BE867269A (fr) Derives de thiopropanoylamino-acides
BR7802097A (pt) Eixo articulado
SE7711581L (sv) Xantin-derivat
JPH0246580B2 (ja) 1*44jihidoroo2*66jimechirupirijinn3*55jikarubonsanjesuteruoyobigaikagobutsuofukumuanteikasoseibutsu
DK543178A (da) Thiodydantoinderivater
SE7803057L (sv) Bensimidazolderivat
SE7804446L (sv) Tienamycinderivat
SE7807149L (sv) Funktionell vetska
SE7805260L (sv) Alkylendiaminderivat
SE7800982L (sv) Meta-sulfonamido-bensamid-derivat
SE7801997L (sv) Dipeptidderivat
BE871422A (fr) Production de 2,6-diaminonebularines
BE863609A (fr) Derives d'oxadiazolopyrimidine
BE863947R (fr) Phenyl-amidines substituees
FI783393A (fi) 2-imino-imidazolidinderivat
MC1183A1 (fr) Derives d'oxadiazolopyrimidine
BE862927A (fr) Nouvelles sulfonylhydrazones de 1,4-dioxo- et 4-oxoquinoxaline-2-carboxaldehyde
SE7808819L (sv) Tiazinderivat
SE7803419L (sv) Kinazolinderivat
BR7808456A (pt) Novos derivados de pirazina